Oncology approvals are on an upward trend
Interviewee/Contributor
Bruno Pagliara
Organisation
MedNous
Cancer (Oncology)
A new paradigm for cancer therapy emerges
Interviewee/Contributor
Victoria English
Organisation
MedNous
A new concept for preventing tumour metastases
Interviewee/Contributor
Anders Månsson
Organisation
RhoVac AB
Highlights from the 2020 ASCO virtual meeting
Interviewee/Contributor
Bruno Pagliara
Organisation
Unlocking the potential of PSMA as a cancer target
Interviewee/Contributor
Brian McGuinness and Theodora Harold
Organisation
Crescendo Biologics Ltd
New cancer drugs have unique mechanisms of action
Interviewee/Contributor
Bruno Pagliara
Organisation
Oncology specialist Bruno Pagliara
Late-stage oncology pipeline is robust
Interviewee/Contributor
Bruno Pagliara
Organisation
MedNous
A meeting of minds at AstraZeneca
Interviewee/Contributor
José Baselga
Organisation
AstraZeneca Plc
Groundbreaking genomic study of cancer published
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
The US continues to lead in oncology approvals
Interviewee/Contributor
Bruno Pagliara
Organisation
MedNous